Effects of Once-Daily, Extended-Release Memantine on Individual Activities of Daily Living in Patients with Moderate to Severe Alzheimer's Disease

被引：0
|
作者：
Tocco, Michael
Hendrix, Suzanne
Miller, Michael L.
Pejovic, Vojislav
Graham, Stephen M.
机构：
来源：
ANNALS OF NEUROLOGY | 2011年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S57 / S58
页数：2
相关论文
共 50 条
  • [31] Behavioral Effects of Extended-Release Memantine (28 mg, Once Daily) across a Wide Range of Disease Severity in Patients with Moderate to Severe Alzheimer's Disease: Post Hoc Analysis from a Randomized Trial
    Tocco, Michael
    Hendrix, Suzanne
    Miller, Michael
    Pejovic, Vojislav
    Graham, Stephen
    NEUROLOGY, 2013, 80
  • [32] Extended-Release Memantine (28 mg, Once Daily) and Sustained Behavioral Improvement: Post Hoc Responder Analysis from a Randomized Trial in Patients with Moderate to Severe Alzheimer's Disease
    Cummings, Jeffrey
    Hendrix, Suzanne
    Miller, Michael
    Pejovic, Vojislav
    Graham, Stephen
    Tocco, Michael
    NEUROLOGY, 2012, 78
  • [33] Safety and tolerability of once-daily versus twice-daily memantine: a randomised, double-blind study in moderate to severe Alzheimer's disease
    Jones, Roy W.
    Bayer, Antony
    Inglis, Fraser
    Barker, Andrew
    Phul, Ravinder
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2007, 22 (03) : 258 - 262
  • [34] Extended-release memantine (28 mg, once daily) and sustained cognitive improvement: Post hoc responder analysis from a randomized trial in patients with moderate to severe Alzheimer's disease.
    Tocco, M.
    Hendrix, S.
    Miller, M. L.
    Pejovic, V.
    Graham, S. M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2012, 60 : S197 - S197
  • [35] Development and Optimization of Once-Daily Extended-Release Formulations of Topiramate
    Lambrecht, Lawrence J.
    Todd, Wesley M.
    Halvorsen, Mark B.
    NEUROLOGY, 2011, 76 (09) : A50 - A50
  • [36] Once-daily extended-release levetiracetam reduces seizure frequency
    Nature Clinical Practice Neurology, 2009, 5 (2): : 63 - 63
  • [37] Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets
    deVries, Tina
    Dentiste, Angela
    Di Lea, Clifford
    Pichette, Vincent
    Jacobs, David
    CNS DRUGS, 2019, 33 (08) : 783 - 789
  • [38] Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets
    Tina deVries
    Angela Dentiste
    Clifford Di Lea
    Vincent Pichette
    David Jacobs
    CNS Drugs, 2019, 33 : 783 - 789
  • [39] Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease
    Galasko, D
    Schmitt, F
    Thomas, R
    Jin, S
    Bennett, D
    Ferris, S
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2005, 11 (04) : 446 - 453
  • [40] Efficacy and safety of once-daily (qd) pramipexole extended-release for advanced Parkinson's disease
    Schapira, A.
    Barone, P.
    Hauser, R.
    Mizuno, Y.
    Poewe, W.
    Rascol, O.
    Busse, M.
    Juhel, N.
    Salin, L.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S133 - S133
12345